Colorado Mother Works to Raise Awareness About Addiction and Self-Harm

Grand Junction resident Andrea Thomas lost her daughter Ashley to counterfeit oxycodone in June 2018. Now, she is determined to protect others. Her new foundation, Voices for Awareness, promotes awareness about substance abuse and self-harm. On July 27, 2019, the organization will hold its first conference—free to the public—at Costa Mesa University, as well as the “Fight for Awareness,” a professional boxing event in which fighters from all over Colorado will dedicate their match to a loved one lost to substance abuse or suicide.

[...]

Former FBI Director Warns About the Hidden Risks of Drug Importation

In this editorial published on April 30, 2019, former FBI Director Louis Freeh talks about the safety risks of drug importation: “There are hidden risks and costs associated with the scheme that have not been getting much attention which impact your health and Colorado law enforcement’s ability to keep us safe.”

[...]

New York District Attorney Indicts Major Online Drug Fake Xanax and Illicit Drug Seller

The office of Manhattan District Attorney Cyrus R. Vance Jr. announced the largest counterfeit pill seizure in New Jersey history this month. In addition to large quantities of other illicit drugs, between 420,000 and 620,000 counterfeit Xanax were discovered during the arrest and search of Chester Anderson, Jarrette Codd, and Ronald MacCarty for their alleged role in selling $2.3 million worth of illicit drugs via the internet.

[...]

Economist questions the fundamentals of importation: “It flunks a basic policy analysis.”

In this editorial published on April 26, 2019, Douglas Holtz-Eakin, economist and President of American Action Forum, questions economic truths about drug importation:

“Drug reimportation has long been the fool’s gold of health policy, and the Florida bill is no different. It flunks a basic policy analysis. But most amazing, it is drafted to raise hope, but not actually help Floridians.”

[...]

Journalist on drug importation: “There is a real risk.”

In this piece published in the Washington Free Beacon on April 25, 2019, staff writer Charles Fain Lehman explores issues around Florida’s drug importation proposal. “Critics,” he notes, “fear that the actual realities of regulatory oversight—especially in the hand of an as-yet-unnamed private vendor—will simply be too challenging to manage responsibly.”

[...]

Utah pharmacist and state senator: Importation raises “serious concerns about drug safety”

In this piece, which was published in The Deseret News on April 24, 2019, pharmacist and Utah State Senate Majority Leader Evan Vickers raises serious concerns about importation as a strategy to lower drug prices:

“Anyone who truly understands how drugs are sold and distributed in the U.S. knows that there are very solid technical reasons that such importation is not viable. There are also serious concerns about drug safety, since the CHS cannot guarantee origin and purity on foreign-sourced drugs.”

[...]